Automatic quantification of myocardial motion in older adults
老年人心肌运动的自动量化
基本信息
- 批准号:9789927
- 负责人:
- 金额:$ 7.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-21 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAgeAreaArtificial IntelligenceBiological MarkersBiomechanicsC-reactive proteinCardiacCardiomyopathiesCardiovascular DiseasesCardiovascular systemChicagoCine Magnetic Resonance ImagingClinicalClinical ResearchComorbidityCoronaryCoronary ArteriosclerosisDataData SetDevelopmentDiabetes MellitusDiagnosisDiseaseEchocardiographyElderlyEventFunctional disorderFundingFutureGelatinase BGoalsHeartHeart failureHypertensionImageImpairmentIncidenceIndividualLDL Cholesterol LipoproteinsLeftLeft Ventricular Ejection FractionLeft Ventricular MassLeft ventricular structureLongitudinal observational studyMRI ScansMachine LearningMagnetic Resonance AngiographyMagnetic Resonance ImagingManualsMeasuresMedicineMethodsMotionMyocardialMyocardial IschemiaMyocardial dysfunctionMyocardiumNational Heart, Lung, and Blood InstituteOlder PopulationOutcomeParticipantPatientsPatternPeroxidasesPopulationPreventionProspective StudiesProtocols documentationRadialRecording of previous eventsResearch Project GrantsRiskRisk stratificationScanningSeriesSmokingTarget PopulationsTechniquesTestingThickTimeTrainingVentricularbaseburden of illnesscardiovascular risk factorclinical practicecoronary plaquecostcost effectivedesigndiabetic patientfollow-uphealthy agingheart damagehuman old age (65+)human subjectimaging biomarkerimprovedindexingmyocardial damagequantitative imagingtool
项目摘要
Abstract
Heart failure (HF) is a common condition that represents the end stage of cardiovascular diseases (CVDs)
subsequent to progressing myocardial damage or ischemia. In populations at ages 65 and older, coronary
artery disease (CAD) serves as the leading cause of HF. Although low left ventricular (LV) ejection fraction
(EF) is a major evidence for the diagnosis of HF in clinical practice, impaired regional myocardial dysfunction is
expected to present the existence of CAD in its early stage.
Heart deformation analysis (HDA) is a cutting-edge myocardial motion analysis technique that is able to
automatically track the myocardium borders on time frames and calculate global and regional cardiac
functional and motional indices on existing cine images without extra scans. In the present study, we will use
the HDA tool to analyze existing cine images of CHARISMA study. From 2009 to 2012, cardiac MRI exams
(including coronary wall imaging and cine MRI at two-chamber, four-chamber and short-axis views) and
concurrent tests for traditional cardiovascular risk factors were performed on 440 older participants (age: 65 -
84 years old at the time of MRI scans) without documented history of CVDs. During the present R03 project
(2019-2021), CHARISMA participants would have been followed-up for 10 - 12 years. We plan to relate newly-
acquired regional myocardial motion indices (displacement, velocity, strain and strain rate) to clinical
outcomes, existing coronary wall measures and results of lab tests in CHARISMA datasets. We will test the
overall hypothesis that regional myocardial motion indices have the potential to present cardiovascular risk in
asymptomatic elderly. Three specific aims are: 1) Predict cardiovascular events using baseline regional
myocardial motion indices; 2) Relate regional myocardial motion indices to MRI-derived features of coronary
remodeling; and 3) Determine correlations between regional myocardial motion indices and traditional
cardiovascular risk biomarkers/conditions collected in CHARISMA study.
No new MRI scans or lab tests are required in this project. Through a cost-effective approach, the immediate
objective of the proposed project is to evaluate the clinical value of regional myocardial motion for
cardiovascular risk stratification in asymptomatic older adults, a major target population of cardiovascular
prevention. This study will also help us better understand the correlations between impaired myocardial
function/motion and subclinical CAD burden. Furthermore, the results will facilitate the selection of quantitative
imaging biomarkers and their optimal cut-off points for predicting cardiovascular events in future clinical
studies.
抽象的
心力衰竭(HF)是代表心血管疾病(CVD)的终点的常见状况
在进展心肌损伤或缺血之后。在65岁及以上的人口中
动脉疾病(CAD)是HF的主要原因。虽然低左心室(LV)射血分数
(EF)是在临床实践中诊断HF的主要证据,区域心肌功能障碍受损是
预计将在早期阶段呈现CAD的存在。
心脏变形分析(HDA)是一种尖端的心肌运动分析技术,能够
自动在时间范围内自动跟踪心肌边界并计算全球和区域心脏
现有的Cine图像的功能和动作指数无需额外扫描。在本研究中,我们将使用
HDA工具分析了现有的魅力研究的Cine图像。从2009年到2012年,心脏MRI考试
(包括冠状动脉墙成像和两腔的Cine MRI,四腔和短轴视图)和
对440名年龄较大的参与者进行了对传统心血管危险因素的同时测试(年龄:65--
MRI扫描时84岁)没有记录CVD的历史。在目前的R03项目中
(2019-2021),魅力参与者将被跟进10至12年。我们计划新近联系
获得的区域心肌运动指数(位移,速度,应变率和应变率)
结果,现有的冠状动脉墙测量和魅力数据集中实验室测试的结果。我们将测试
总体假设,区域心肌运动指数有可能出现心血管风险
无症状的老年人。三个具体目标是:1)使用基线区域预测心血管事件
心肌运动指数; 2)将区域心肌运动指数与冠状动脉的MRI衍生特征相关联
重塑; 3)确定区域心肌运动指数与传统之间的相关性
魅力研究中收集的心血管风险生物标志物/条件。
该项目不需要新的MRI扫描或实验室测试。通过一种经济有效的方法,即时
拟议项目的目的是评估区域心肌运动的临床价值
无症状老年人的心血管风险分层,这是心血管的主要目标人群
预防。这项研究还将帮助我们更好地了解心肌受损之间的相关性
功能/运动和亚临床CAD负担。此外,结果将有助于选择定量
成像生物标志物及其最佳临界点,以预测未来临床中的心血管事件
研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kai Lin其他文献
Kai Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kai Lin', 18)}}的其他基金
Quantitative MRI for the assessment of subclinical CAD in T2DM
定量 MRI 评估 T2DM 亚临床 CAD
- 批准号:
9307576 - 财政年份:2015
- 资助金额:
$ 7.9万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty
Cafe Move:预防与年龄相关的身体虚弱的新计划
- 批准号:
10861960 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias
年度健康就诊政策:对患有阿尔茨海默病及其相关痴呆症的医疗保险受益人的早期痴呆诊断和医疗质量差异的影响
- 批准号:
10729272 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Augmenting Pharmacogenetics with Multi-Omics Data and Techniques to Predict Adverse Drug Reactions to NSAIDs
利用多组学数据和技术增强药物遗传学,预测 NSAID 的药物不良反应
- 批准号:
10748642 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别: